Allogene Therapeutics Inc (ALLO)
Operating Cash Flow Growth
18.02%
Quarterly · Period ending:
ALLO Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported18.02%period ending
Latest reported18.02%period ending
ALLO Quarterly Cash from Operations YoY % (-605220.00% → 18.02%)
Year-over-year change
High-resolution chart · PNG
ALLO operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 18.022% | |
| 75.6032% | |
| 24.7943% | |
| 32.7032% | |
| 38.6205% | |
| 5.3132% | |
| 31.67% | |
| 20.5565% | |
| -2.7984% | |
| 16.1167% | |
| 13.5097% | |
| -16.525% | |
| -45.4398% | |
| 2.3418% | |
| -36.667% | |
| 2.5021% | |
| -3.3058% | |
| -38.3332% | |
| -355.4987% | |
| -30.0362% | |
| -54.0736% | |
| -20.8753% | |
| 80.156% | |
| -17.7016% | |
| -7.3477% | |
| -34.879% | |
| -134.0068% | |
| -86.4273% | |
| -311.6421% | |
| -605,220% |